comparemela.com
Home
Live Updates
Myelofibrosis Related Anemia - Breaking News
Pages:
Latest Breaking News On - Myelofibrosis related anemia - Page 1 : comparemela.com
McKesson : OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson -September 20, 2023 at 09:07 am EDT
CARY, N.C., Sept. 20, 2023-Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for.
Claire crye
Mckesson corporation
Specialty pharmacy solutions
Drug administration
Ela lourido
Hematol oncol
Myelofibrosis related anemia
Emerging therapeutic
US FDA accepts new drug application for GSKs momelotinib for the treatment of myelofibrosis
Regulatory submission included data from the pivotal MOMENTUM phase III clinical trial that met all primary and key secondary efficacy endpoints.
United states
American society of clinical oncology annual meeting
Sierra oncology inc
European hematology association
Drug administration
New drug application
Prescription drug user fee act
Total symptom score
Transfusion independence
Splenic response rate
Clinical oncology annual meeting
Myelofibrosis symptom assessment
Sierra oncology
Hematol oncol
Myelofibrosis related anemia
Emerging therapeutic
vimarsana © 2020. All Rights Reserved.